Santiago de Cuba gets ready for third phase of vaccine candidate
Santiago de Cuba gets ready for third phase of vaccine candidate
Santiago de Cuba, Mar 8 (Prensa Latina) This city in eastern Cuba is preparing today for the third phase of clinical trials of the Abdala Covid-19 vaccine candidate, which it will share with Guantanamo, after conducting two previous ones with good results. Awaiting the approval to start that stage by the Center of State Medical Equipment and State Control of Cuba, authorities are preparing vaccination facilities and the experts in charge of this phase with some 30,000 volunteers.
The Saturnino Lora Provincial Teaching Hospital will remain the epicenter of these tests, which started early in December, 2020, with 132 and 660 individuals, respectively, strictly supervised by experts from the Genetic Engineering and Biotechnology Center (CIGB), which created the vaccine.
With COVID-19 pandemic, Cuba s medical system faces its biggest test yet Nora Gámez Torres and Mario J. Pentón, The Miami Herald
Feb. 8 Cuba managed to navigate the first waves of the coronavirus pandemic thanks to a strict quarantine and a public health system that, although hit by many shortages in recent years, remains stronger than its counterparts in many of its Caribbean neighbors. But a new wave of cases has cast a spotlight on the lack of resources lashing the island s hospitals.
Doctors in cities like Cienfuegos say the shortages of PCR tests and personal protection equipment have put them at risk. In Havana, the number of patients in hospitals has been rising, and the government says it is adding ICU beds. Health professionals say they are concerned about a shortage of medical workers to help care for COVID-19 patients.
Final Call News
Medic holds Nasalferon. Photo: Facebook
(GRANMA) As a preventative measure, given the COVID-19 situation in the country, this immune system booster is being administered to travelers arriving in Cuba, as well as members of their households.
Cuba began administering Nasalferon to travelers and their families on Jan. 7, a drug produced by the country’s biotechnology industry to prevent the transmission of SARS-COV-2 and strengthen the immune system, reported the Cuban News Agency.
According to information from a recent session of Havana’s Provincial Defense Council, the application of the medication via nasal drops will be conducted first in the municipalities of Boyeros and Diez de Octubre, to subsequently be extended to the rest of the capital.
Cuba will administer Nasalferon to travelers and families
Cuba will administer Nasalferon to travelers and families
Havana, Jan 7 (Prensa Latina) Cuba will start administering Nasalferon, a drug produced by the country s biotechnology industry, to travelers and their relatives in order to prevent the replication of the SARS-CoV-2 coronavirus, and strengthen their immune system.
As reported in a session of the Provincial Defense Council of Havana, this medicine will be administered initially in the municipalities of Boyeros and Diez de Octubre, and will be extended gradually to the rest of the capital.
The director of Science and Technological Innovation at the Ministry of Public Health, Ileana Morales, explained that a drop will be administered nasally in the morning and another one at night for a period of five to ten days.